Antibodies
3 July 2009
Phase III Study Showed Lucentis Improved Vision in Patients with Branch Retinal Vein Occlusion30 June 2009
Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial26 June 2009
Cimzia®, the only PEGylated anti-TNF, recommended for approval in the EU for rheumatoid arthritis24 June 2009
MorphoSys Reports Filing for Phase 1b/2a Trial for its Lead Program MOR103 in Rheumatoid Arthritis23 June 2009
Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration16 June 2009
FDA EXTENDS REVIEW OF ARZERRA™ (OFATUMUMAB)16 June 2009
Immunomedics Reports New Antibody for Pretargeted Imaging and Therapy of Colorectal Cancer16 June 2009
Adimab Launches Novel Antibody Discovery Platform and Announces Discovery Programs with Merck and Roche15 June 2009
Immunomedics Reports Updated Phase II Results With Radiolabeled Epratuzumab in Non-Hodgkin’s LymphomaNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports